# Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients

> **NCT06040944** · — · COMPLETED · sponsor: **Fayoum University** · enrollment: 64 (actual)

## Conditions studied

- Schizophrenia Spectrum and Other Psychotic Disorders
- Periodontal Diseases

## Interventions

- **DRUG:** antipsychotic drugs inducing hyperprolactinemia

## Key facts

- **NCT ID:** NCT06040944
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040944, "Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06040944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*